|
Status |
Public on Aug 17, 2017 |
Title |
Primary_Tumor 1074 |
Sample type |
RNA |
|
|
Source name |
Tissue samples taken from colorectal cancer patients
|
Organism |
Homo sapiens |
Characteristics |
center: Limoges Sex: Male age: 71 who performance status: 2 tumor location: Right colon synchronous metastase: Yes pn: pN2 pt: pT2 regimen: FOLFIRI response category: SD response status: NR pfs censored: 1 pfs: 6.406570911 os censored: 1 os: 6.406570911
|
Treatment protocol |
Samples were collected before chemotherapy
|
Extracted molecule |
total RNA |
Extraction protocol |
Rneasy kit (Qiagen) for total RNA was performed according to the manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the Affymetrix protocol.
|
|
|
Hybridization protocol |
Following fragmentation, cRNA were hybridized on GeneChip Human Genome U133 Plus 2.0 array.
|
Scan protocol |
GeneChips were scanned using a laser scanner.
|
Data processing |
Processing and normalization was done using the Robust Multi-array Average (RMA)
|
|
|
Submission date |
Sep 12, 2015 |
Last update date |
Aug 17, 2017 |
Contact name |
Pierre Martineau |
E-mail(s) |
pierre.martineau@inserm.fr
|
Phone |
+33 4 67 61 37 43
|
Organization name |
Inserm
|
Department |
IRCM
|
Street address |
208 Rue des Apothicaires
|
City |
Montpellier Cedex 5 |
ZIP/Postal code |
34298 |
Country |
France |
|
|
Platform ID |
GPL570 |
Series (2) |
GSE72969 |
Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies (part 2) |
GSE72970 |
Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies |
|